What's happening
This bill requires a study on the impact of mandating health insurance coverage for Lyme disease treatment in New York.
Why it matters
The study will examine not just whether insurance should cover Lyme disease treatment, but also how such a mandate could affect healthcare costs for providers, insurance premiums for consumers, and the overall fiscal impact on New York State. This could influence future decisions about insurance mandates in other areas.
Findings from the report could highlight gaps in current insurance coverage and reveal whether patients with Lyme disease are facing significant out-of-pocket costs or barriers to care. This could shape both public opinion and legislative priorities around access to treatment.
The commission's recommendations could serve as a blueprint for future state health policy, potentially impacting how other diseases are considered for insurance mandates and how costs are distributed among stakeholders. The results may inform broader debates about balancing public health needs with insurance affordability and state budgets.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
New York State Health Care Quality and Cost Containment Commission
The bill would require the commission to study Lyme disease treatment coverage requirements and report findings and recommendations by November 30, 2018.
Health insurers and policyholders
The study would assess how requiring certain health plans to cover Lyme disease treatment would affect insurance premiums.
Health care providers
The study would examine how a Lyme disease treatment coverage requirement would affect their costs.
People with Lyme disease
The bill would require a study of treatment coverage requirements, but would not itself mandate coverage.
Headline styles
Study Lyme Treatment Coverage
Plain English, a few words. Used as the page title.
Sponsors
14 Co-sponsors
4 Multi-sponsors
History
- Referred to insurance
- Referred to insurance
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
6927
2017-2018 Regular Sessions
IN ASSEMBLY
March 24, 2017
Introduced by M. of A. HUNTER -- read once and referred to the Committee on Insurance
AN ACT to amend the insurance law, in relation to directing the New York state health care quality and cost containment commission to study and report upon the impact of requiring that certain health insurance plans provide coverage for treatment of lyme disease
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Section 213 of the insurance law is amended by adding a new subsection (e) to read as follows:
(e) The commission shall cause a study to be performed on the impact of requiring certain health insurance plans to provide coverage for treatment of lyme disease. Such study shall include an assessment of the impact of such a requirement on costs to providers, the cost of insurance premiums, and the fiscal impact to the state. The commission shall submit a report of the findings, conclusions and recommendation of such study, on or before November thirtieth, two thousand eighteen, to the governor, the temporary president of the senate, the speaker of the assembly, the chairs of the senate and assembly insurance committees, and the chairs of the senate and assembly health committees.
§ 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD10729-01-7
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.